Abstract: A secondary battery reduces or prevents the likelihood of lifting or twisting by increasing the fixing force between an electrode plate and a separator of a stacked electrode assembly, and reduces or prevents the likelihood of damage to an electrode plate due to being pressed by a lower insulating member of a cap assembly. A secondary battery may include an electrode assembly including first and second electrode plates alternately stacked with a separator therebetween, a first current collector plate coupled to the first electrode plate, a case accommodating the electrode assembly and the first current collector plate, a cap plate coupled to the case, a first terminal contacting the first current collector plate, and having an upper end penetrating the cap plate, and an insulating tape covering upper and lower surfaces of the electrode assembly, fixing the electrode assembly, and extending along a longitudinal direction of the cap plate.

Abstract: Provided is a display device including a display panel, an optical sensor, a timing controller, a scan driver, a data driver, and an image controller. The timing controller controls an image refresh rate of the display panel based on are fresh rate control signal. Thus, the display device provides improved visibility.

Abstract: An apparatus for a high-intensity focused ultrasound (HIFU) generation device includes: an ultrasonic radiation frame comprising at least one coupling hole formed therein; at least one transducer holder inserted into the at least one coupling hole, wherein the at least one transducer holder is detachably coupled to the ultrasonic radiation frame; and at least one transducer mounted in the at least one transducer holder. At least a part of a side surface of a respective transducer holder of a respective transducer holder comprises an opening formed therein.

Abstract: A manufacturing method of a window includes: radiating a laser to a glass; immersing a laser-irradiated glass in a KOH solution to form a groove in the glass and to perform a primary reinforcement on the glass; masking the groove of a primarily reinforced glass; and performing a secondary reinforcement on a masked glass.

Abstract: A method for providing an electronic package structure includes providing a substrate having a die pad having a die pad top surface and an opposing die pad bottom surface, leads laterally spaced apart from the die pad, and a substrate encapsulant interposed between the die pad and the leads and includes a substrate top surface and an opposing substrate bottom surface. The substrate encapsulant is provided such that the die pad and the leads protrude outward from the substrate bottom surface. The method includes providing an electronic device having opposing major surfaces and a pair of opposing outer edges. The method includes connecting the electronic device to the substrate such that one major surface of the electronic device is spaced apart from the die pad top surface and upper surfaces of the leads, and the outer edges overlap an opposing pair of the leads.

Abstract: A high-intensity focused ultrasound generator according to the present invention has a plurality of transducers mounted to respective transducer holders and the transducer holders detachably coupled to an ultrasonic radiation frame, and thus allows easy replacement and repair of the transducers in a separate manner, and further, by sealing between the inner surface of the transducer holder and the transducer by means of the adhesion of a flexible glue, leakage may be prevented, and the front surface of the transducer is not blocked by the glue, and thus loss of ultrasonic energy generated forward from the front surface of the transducer may be prevented and efficiency may be enhanced.

Abstract: Disclosed is a pharmaceutical composition containing a compound useful for inhibiting neurotoxicity caused by beta amyloid. The pharmaceutical composition of the present disclosure contains 1,3,5,7-tetrakis(aminomethyl)adamantane, an analogous compound thereof or a salt thereof as an active ingredient. The inventors have studied methods for reducing the toxicity of beta amyloid oligomers based on the formation mechanism of dodecamers in consideration of the fact that especially the dodecamers from among the beta amyloid oligomers exhibit a significant activity as a toxin for synapses and neurons in cranial nerve diseases. The inventors have confirmed that the disclosed compound can induce structural epitope deformation of the dodecamer and thereby reduce toxicity of the beta amyloid oligomers.